PE Ratio:
92.44-1.68(-1.78%)Summary
- As of today, TGTX price to earnings ratio is 92.44, with a fall of -1.68 (-1.78%) during the most recent trading session on October 22, 2025.
- TGTX PE ratio is now -95.38% below its all-time high of 2001.78.
Performance
TGTX PE Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
PE Ratio Formula
P/E = Price
TTM Earnings Per Share
Price
TTM Earnings Per Share
TTM Earnings Per Share
TGTX PE Ratio Trends
PeriodPeriod | PE RatioPE Ratio | PricePrice | TTM EPSTTM EPS | TTM RevenueTTM Revenue |
---|---|---|---|---|
1D1 Day | -1.8% | -1.8% | +53.4% | +17.5% |
1M1 Month | -1.1% | -1.1% | - | - |
3M3 Months | -7.4% | -7.4% | +53.4% | +17.5% |
6M6 Months | -40.6% | -8.9% | - | - |
YTDYTD | -57.1% | +14.9% | - | - |
1Y1 Year | - | +42.6% | -37.6% | +31.0% |
5Y5 Years | - | +26.1% | +117.8% | +10000.0% |
TGTX PE Ratio Highs & Lows
PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
---|---|---|---|---|---|
1M | 1-Month | 98.42 | -6.1% | 90.22 | +2.5% |
3M | 3-Month | 100.48 | -8.0% | 70.52 | +31.1% |
6M | 6-Month | 186.52 | -50.4% | 70.52 | +31.1% |
1Y | 1-Year | 307.73 | -70.0% | 70.52 | +31.1% |
3Y | 3-Year | 1521.43 | -93.9% | 28.68 | +222.3% |
5Y | 5-Year | 1521.43 | -93.9% | 28.68 | +222.3% |
All-Time | All-Time | 2001.78 | -95.4% | 0.05 | >+9999.0% |
TGTX PE Ratio History
Date | Value |
---|---|
2025 | 92.44(-57.1%) |
2024 | 215.46(-82.3%) |
Date | Value |
---|---|
2023 | 1220.00(>+9900.0%) |
2011 | 0.11(-98.2%) |
2010 | 5.98 |
FAQ
- What is TG Therapeutics, Inc. price to earnings ratio?
- What is the all-time high PE ratio for TG Therapeutics, Inc.?
- What is TGTX price to earnings ratio year-to-date change?
What is TG Therapeutics, Inc. price to earnings ratio?
The current PE ratio of TGTX is 92.44
What is the all-time high PE ratio for TG Therapeutics, Inc.?
TG Therapeutics, Inc. all-time high price to earnings ratio is 2001.78
What is TGTX price to earnings ratio year-to-date change?
TG Therapeutics, Inc. price to earnings ratio has changed by -123.02 (-57.10%) since the beginning of the year